For PCOS, steady cardio and HIIT improve different things

Polycystic ovary syndrome affects up to 13% of reproductive-aged women and carries raised cardiometabolic risk through insulin resistance, unfavourable blood lipids and obesity. Exercise sits at the heart of lifestyle advice for PCOS, yet the guidance rarely says what kind or how hard. Whether a woman should favour hard intervals, steady moderate sessions or gentler movement has been an open question, and different intensities could plausibly act on different parts of the metabolic picture. This review set out to compare them head to head.

The researchers ran a systematic review and network meta-analysis of 23 randomised controlled trials covering 1,192 women with PCOS, comparing high-intensity interval training, moderate-intensity continuous training, low-intensity training and no exercise. Primary outcomes were BMI, insulin resistance measured by HOMA-IR, and maximal oxygen uptake. Secondary outcomes included fasting insulin, lipid profile, glucose, HbA1c and blood pressure. Ranking statistics identified the most effective intervention for each outcome, and the protocol was registered in advance.

Moderate-intensity continuous training significantly reduced insulin resistance, whereas high-intensity interval training did not reach significance on that measure. HIIT significantly increased VO2max, and both HIIT and moderate training reduced fasting insulin and LDL cholesterol. Nothing moved BMI, HDL cholesterol, triglycerides, glucose, HbA1c or blood pressure at any intensity. The rankings favoured HIIT for fitness, fasting insulin and LDL, and moderate training for insulin resistance. The certainty of the evidence ranged from low to moderate across outcomes.

Exercise was already recommended for PCOS, but this analysis adds the missing nuance about intensity, and it complicates the assumption that harder training is always metabolically better: for insulin resistance itself, moderate steady work was the design that reached significance. The consistent nulls for weight, glucose and blood pressure are also informative, suggesting exercise alone does not shift those markers in these trials. Open questions remain about how to individualise intensity, and the low to moderate certainty means the specific numbers may shift as more trials arrive.

For a woman with PCOS, this is a reason to think of exercise intensity as a dial that selects which health markers respond, rather than a ladder where harder always wins. Steady moderate cardio was the approach with a significant effect on insulin resistance, while intervals delivered the fitness gains, and both improved fasting insulin and LDL cholesterol. It is equally worth knowing what did not change: weight, glucose and blood pressure held steady, so judging an exercise habit by the scale alone would miss where the benefits actually landed.